1. Defriez M, Griffiths D, Millett C. The perception of the current provision of care for multiple
sclerosis sufferers in the community. Primary health care res develop 2003; 4(3):233-43.
Level of Evidence: 3
2. Ford HL, Gerry E, Johnson MH, et al. Health status and quality of life of people with
multiple sclerosis. Disabil rehabil 2001; 23(12):516-21. Level of Evidence: 3
3. Neri M, Kroll T. Understanding the consequences of access barriers to health care:
experiences of adults with disabilities. Disabil rehabil 2003; 25(2):85-96.
Level of Evidence: 3
4. Welburn J. Co-ordinating specialists care packages for people with multiple sclerosis.
Community nurse 2000; 6(7):11-2. Level of Evidence: 4
5. Barnwell AM, Kavanagh DJ. Prediction of psychological adjustment to multiple sclerosis.
Soc sci med 1997; 45(3):411-8. Level of Evidence: 3
6. Britell C, Burks J, Schapiro R. Chapter 12: Introduction to symptom and rehabilitative
management: disease management model. in: Burks J , Johnson K, eds. Multiple sclerosis:
diagnosis, medical management, and rehabilitation. New York: Demos Medical Publishing,
Inc, 2000. Level of Evidence: 4
7. Burks J. Multiple sclerosis care: an integrated disease-management model. J Spinal cord
med 1998; 21(2):113-6. Level of Evidence: 4
8. Dyck I. Hidden geographies: the changing lifeworlds of women with multiple sclerosis. Soc
sci med 1995; 40(3):307-20. Level of Evidence: 3
9. Dyck I, Jongbloed L. Women with multiple sclerosis and employment issues: a focus on
social and institutional environments. Can J Occup ther 2000; 67(5):337-46.
Level of Evidence: 3
10. Finlayson M. Concerns about the future among older adults with multiple sclerosis.
Am J Occup ther 2004; 58(1):54-63. Level of Evidence: 3
11. Forwell S. Managing the ordinary things of everyday life. MS in focus 2003; 1:9-11.
Level of Evidence: 4
12. Gordon P, Lewis MD, Wong D. Multiple sclerosis: strategies for rehabilitation counselors.
J Rehabil 1994; 60(3):34-8. Level of Evidence: 3
13. Gordon PA, Feldman D, Shipley B, et al. Employment issues and knowledge regarding ADA
of persons with multiple sclerosis. J Rehabil 1997; 63(4):52-8. Level of Evidence: 3
14. Gulick EE. Correlates of quality of life among persons with multiple sclerosis. Nurs res
1997; 46(6):305-11. Level of Evidence: 3
15. Hakim E, Bakheit A, Bryant T, et al. The social impact of multiple sclerosis--a study of 305
patients and their relatives. Disabil rehabil 2000; 22(6):288-93. Level of Evidence: 3
16. Haselkorn J, Leer S, Hall J, et al. Chapter 17: Mobility. in: Burks J, Johnson K, eds Multiple
sclerosis: diagnosis, medical management, and rehabilitation. New York: Demos
Medical Publishing, Inc., 2000. Level of Evidence: 4
17. Holland N, Murray T, Reingold S. Multiple sclerosis: a guide for the newly diagnosed.
Second edition. New York: Demos Medical Publishing, Inc., 2002. Level of Evidence: 4
18. Hopman W, Coo H, Brunet D, et al. Longitudinal assessment of health-related quality of life
(HRQL) of patients with multiple sclerosis. Inter J of MS care 2000; 2(4):3.
Level of Evidence: 3
19. Johnson K, Yorkston K, Klasner E, et al. The cost and benefits of employment: a qualitative
study of experiences of persons with multiple sclerosis. Arch phys med rehabil 2004;
85(2):201-9. Level of Evidence: 3
20. Leino-Kilpi H, Luoto E, Katajisto J. Elements of empowerment and MS patients. J Neurosci
nurs 1998; 30(2):116-23. Level of Evidence: 3
21. Lundmark P, Branholm IB. Relationship between occupation and life satisfaction in people
with multiple sclerosis. Disabil rehabil 1996; 18(9):449-53. Level of Evidence: 3
22. McCabe MP, McKern S. Quality of life and multiple sclerosis: comparison between people
with multiple sclerosis and people from the general population. J Clin psychol med settings
2002; 9(4):287-95. Level of Evidence: 3
23. Mohr DC, Dick LP, Russo D, et al. The psychosocial impact of multiple sclerosis: exploring
the patient's perspective. Health psychol 1999; 18(4):376-82. Level of Evidence: 3
24. O'Hara L, De Souza L, Ide L. A Delphi study of self-care in a community population of
people with multiple sclerosis. Clin rehabil 2000; 14(1):62-71. Level of Evidence: 3
25. Reynolds F, Prior S. Sticking jewels in your life: exploring women's strategies for
negotiating an acceptable quality of life with multiple sclerosis. Qualitative health research
[Special Issue: Care of Self] 2003; 13(9):1225-51. Level of Evidence: 3
26. Roessler R, Rumrill P. Strategies for enhancing career maintenance self-efficacy of people
with multiple sclerosis. J Rehabil 1994; 60(4):54-9. Level of Evidence: 4
27. Rumrill P, Roessler RT, Koch LC. Surveying the employment concerns of people with
multiple sclerosis: a participatory action research approach. J Voc rehabil 1999; 12(2):
75-82. Level of Evidence: 3
28. Rumrill P, Tabor TL, Hennessey ML, et al. Issues in employment and career development
for people with multiple sclerosis: meeting the needs of an emerging vocational
rehabilitation clientele. J Voc rehabil, [Special Issue: Rehabilitation Counseling in the 21st
Century] 2000; 14(2):109-17. Level of Evidence: 4
29. Schwartz CE, Sendor M. Helping others helps oneself: response shift effects in peer
support. Soc sci med 1999; 48(11):1563-75. Level of Evidence: 3
30. Somerset M, Sharp D, Campbell R. Multiple sclerosis and quality of life: a qualitative
investigation. J Health serv res policy 2002; 7(3):151-9. Level of Evidence: 3
31. Multiple Sclerosis Society of Australia. MS and parenting. Lidcombe: 1996. Level of
Evidence: 4
32. Forbes A, While A, Dyson L, et al. Impact of clinical nurse specialists in multiple sclerosis -
synthesis of the evidence. J Adv nurs 2003; 42(5):442-62. Level of Evidence: 4
33. Courts NF, Buchanan EM, Werstlein PO. Focus groups: the lived experience of participants
with multiple sclerosis. J Neurosci nurs 2004; 36(1):42-7. Level of Evidence: 3
34. Department of Health. The expert patient: a new approach to chronic disease management
for the 21st Century. London: 2001. Level of Evidence: 4
35. Freeman J, Ford H, Mattison P, et al. Developing MS healthcare standards: evidence-based
recommendations for service providers. London: The Multiple Sclerosis Society of Great
Britain and Northern Ireland, 2002. Level of Evidence: 4
36. Giesser B. Talking about the diagnosis of multiple sclerosis. New York: National Multiple
Sclerosis Society, 2003. Level of Evidence: 4
37. Halper J, Holland N. Meeting the challenge of multiple sclerosis, Part 2. Am J Nurs 1998;
87(11):39-45. Level of Evidence: 4
38. McLaughlin J , Zeeberg I. Self-care and multiple sclerosis: a view from two cultures. Soc sci
med 1993; 37(3):315-29. Level of Evidence: 3
39. Somerset M, Peters TJ, Sharp DJ, et al. Factors that contribute to quality of life outcomes
prioritised by people with multiple sclerosis. Qual life res 2003; 12(1):21-9.
Level of Evidence: 2b
40. Thorne S, Con A, McGuinness L, et al. Health care communication issues in multiple
sclerosis: an interpretive description. Qual health res 2004; 14(1):5-22. Level of
Evidence: 3
41. Yorkston KM, Johnson K, Klasner ER, et al. Getting the work done: a qualitative study of
individuals with multiple sclerosis. Disabil rehabil 2003; 25(8):369-79. Level of Evidence: 3
42. National Collaborating Centre for Chronic Conditions. Multiple sclerosis: management of
multiple sclerosis in primary and secondary care. Clinical guideline 8. London: National
Institute for Clinical Excellence [Web Page]. 2003; Available at www.nice.org.uk. (Accessed
15 February 2004). Level of Evidence: 4
43. Somerset M, Campbell R, Sharp D, et al. What do people with MS want and expect from
health-care services? Health expect 2001; 4(1):29-37. Level of Evidence: 3
44. Saunders A, Aisen M. Chapter 26: Sexual dysfunction. in: Burks J, Johnson K, eds. Multiple
sclerosis: diagnosis, medical management, and rehabilitation. New York: Demos Medical
Publishing, Inc, 2000. Level of Evidence: 4
45. Schapiro R. Managing the symptoms of multiple sclerosis. Fourth edition. New York: Demos
Medical Publishing, 2003. Level of Evidence: 4
46. Roessler RT, Rumrill PD, Hennessey ML, et al. Perceived strengths and weaknesses in
employment policies and services among people with multiple sclerosis: results of a
national survey. J Prevent assess rehabil 2003; 21(1):25-36. Level of Evidence: 3
47. Rumrill P, Hennesey M. Multiple sclerosis: a guide for rehabilitation and health care
professionals. Springfield: Charles C Thomas Publisher, 2001. Level of Evidence: 3
48. The Canadian Burden of Illness Study Group. Burden of illness of multiple sclerosis: part II:
quality of life. Can J Neurol sci 1998; 25(1):31-8. Level of Evidence: 3
49. Miller DM, Rudick RA, Baier M, et al. Factors that predict health-related quality of life in
patients with relapsing-remitting multiple sclerosis. Mult scler 2003; 9(1):1-5.
Level of Evidence: 2b
50. Peters T, Somerset M, Campbell R, et al. Variables associated with attendance at, and the
perceived helpfulness of, meetings for people with multiple sclerosis. Health soc care
community 2003; 11(1):19-26. Level of Evidence: 3
51. Stuifbergen AK, Becker H, Blozis S, et al. A randomized clinical trial of a wellness
intervention for women with multiple sclerosis. Arch phys med rehabil 2003; 84(4):467-76.
Level of Evidence: 1b
52. Baker LM. Sense making in multiple sclerosis: the information needs of people during an
acute exacerbation. Qual health res 1998; 8(1):106-20. Level of Evidence: 3
53. Bashir K, Whitaker J. Handbook of multiple sclerosis. New York: Lippincott Williams &
Wilkins, 2002. Level of Evidence: 4
54. Box V, Hepworth M, Harrison J. Identifying information needs of people with multiple
sclerosis. Nurs times 2003; 99(49):32-6. Level of Evidence: 3
55. Crigger NJ. Testing an uncertainty model for women with multiple sclerosis. Adv Nurs sci
1996; 18(3):37-47. Level of Evidence: 3
56. Joy J, R Johnston, eds. Multiple sclerosis: current status and strategies for the future.
Washington, DC: National Academy Press, 2001. Level of Evidence: 4
57. Koch T, Kelly S. Understanding what is important for women who live with multiple
sclerosis. Aust J Holist nurs 1999; 6(1):14-24. Level of Evidence: 3
68. De Broe S, Christopher F, Waugh N. The role of specialist nurses in multiple sclerosis: a
rapid and systematic review. Health technol assess 2001; 5(17):1-37. Level of Evidence: 3
69. Thompson AJ. Progress in neurorehabilitation in multiple sclerosis. Curr opin neurol 2002;
15(3):267-70. Level of Evidence: 4
70. McReynolds CJ, Koch LC, Rumrill JrP. Psychosocial adjustment to multiple sclerosis:
Implications for rehabilitation professionals. J Voc rehabil 1999; 12(2):83-91. Level of
Evidence: 4
71. Ko Ko C. Effectiveness of rehabilitation for multiple sclerosis. Clin rehabil 1999; 13 Suppl
1:33-41. Level of Evidence: 4
72. Jonsson A, Dock J, Ravnborg MH. Quality of life as a measure of rehabilitation outcome in
patients with multiple sclerosis. Acta neurol scand 1996; 93(4):229-35. Level of
Evidence: 3
73. Freeman JA, Langdon DW, Hobart JC, et al. Inpatient rehabilitation in multiple sclerosis: do
the benefits carry over into the community? Neurology 1999; 52(1):50-6.
Level of Evidence: 3
74. Thompson AJ. The effectiveness of neurological rehabilitation in multiple sclerosis.
J Rehabil res dev 2000; 37(4):455-61. Level of Evidence: 4
75. Arnoldus JH, Killestein J, Pfennings LE, et al. Quality of life during the first 6 months of
interferon-beta treatment in patients with MS . Mult scler 2000; 6(5):338-42.
Level of Evidence: 2b
76. Bethoux F. Chapter 43: Rehabilitation in multiple sclerosis. in: Cohen J, Rudick R, eds.
Multiple sclerosis therapeutics. Second edition. London: Martin Dunitz Ltd, 2003.
Level of Evidence: 4
58. Miller CM. The lived experience of relapsing multiple sclerosis: a phenomenological study.
J Neurosci nurs 1997; 29(5):294-304. Level of Evidence: 3
59. Nortvedt MW, Riise T. The use of quality of life measures in multiple sclerosis research.
Mult scler 2003; 9(1):63-72. Level of Evidence: 4
60. O'Hara L, Cadbury H, De Souza L, et al. Evaluation of the effectiveness of professionally
guided self-care for people with multiple sclerosis living in the community: a randomized
controlled trial. Clin rehabil 2002; 16(2):119-28. Level of Evidence: 1b
61. Polman C, Thompson A, Murray T, McDonald W. Multiple sclerosis: the guide to treatment
and management. Fifth edition. New York: Demos Medical Publishing, 2001.
Level of Evidence: 4
62. Schwartz CE. Teaching coping skills enhances quality of life more than peer support:
results of a randomized trial with multiple sclerosis patients. Health psychol 1999;
18(3):211-20. Level of Evidence: 1b
63. Slade A, Tennant A, Ford H. Meeting the information needs of people with multiple
sclerosis. Int J Therapy rehab 2003; 10(5):211-7. Level of Evidence: 3
64. Vaughan R, Morrison L, Miller E. The illness representations of multiple sclerosis and their
relations to outcome. Br J Health psychol 2003; 8 (Pt 3):287-301. Level of Evidence: 3
65. Multiple Sclerosis Society of Great Britain and Northern Ireland. Basics of best practice in
the management of multiple sclerosis. London: 1999. Level of Evidence: 4
66. O'Day B. Barriers for people with multiple sclerosis who want to work: a qualitative study.
J Neurol rehabil 1998; 12(3):139-46. Level of Evidence: 3
67. Multiple Sclerosis Society of Canada. Assets and abilities: your guide to work, income
security, and multiple sclerosis. Toronto: 2001. Level of Evidence: 4
48 49
86. Pozzilli C, Brunetti M, Amicosante AM, et al. Home based management in multiple sclerosis:
results of a randomised controlled trial. J Neurol neurosurg psychiatry 2002; 73(3):250-5.
Level of Evidence: 1b
87. Rice G, Incorvaia B, Munari L et al. Interferon in relapsing-remitting MS. Cochrane
database of systematic reviews. Issue 4 edition. Chichester, UK: John Wiley & Sons, Ltd.,
2001. Level of Evidence: 1a
88. Rice GP, Oger J, Duquette P, et al. Treatment with interferon beta-1b improves quality of
life in multiple sclerosis. Can J Neurol sci 1999; 26(4):276-82. Level of Evidence: 2b
89. Schwartz CE, Coulthard-Morris L, Cole B, et al. The quality-of-life effects of interferon
beta- 1b in multiple sclerosis. An extended Q-TWiST analysis. Arch Neurol 1997;
54(12):1475 80. Level of Evidence: 2b
90. Schwid S. Chapter 42: Management of cognitive impairment in multiple sclerosis. in: Cohen
J, Rudick R, eds. Multiple scleroris therapeutics. Second edition. London: Martin Dunitz Ltd,
2003. Level of Evidence: 4
91. Shawaryn MA, Schiaffino KM, LaRocca NG, et al. Determinants of health-related quality of
life in multiple sclerosis: the role of illness intrusiveness. Mult scler 2002; 8(4):310-8.
Level of Evidence: 3
92. Vermersch P, de Seze J, Stojkovic T, et al. Interferon beta1a (Avonex) treatment in multiple
sclerosis: similarity of effect on progression of disability in patients with mild and moderate
disability. J Neurol 2002; 249(2):184-7. Level of Evidence: 2b
93. Zivadinov R, Zorzon M, Tommasi M, et al. A longitudinal study of quality of life and side
effects in patients with multiple sclerosis treated with interferon beta-1a. J Neurol sci
2003; 216(1):113-8. Level of Evidence: 3
77. Bethoux F, Miller DM, Kinkel RP. Recovery following acute exacerbations of multiple
sclerosis: from impairment to quality of life. Mult scler 2001; 7(2):137-42. Level of
Evidence: 2b
78. Schwid SR, Petrie MD, Murray R, et al. A randomized controlled study of the acute and
chronic effects of cooling therapy for MS. Neurology 2003; 60(12):1955-60. Level of
Evidence: 1b
79. Cohen JA, Cutter GR, Fischer JS et al. Benefit of interferon beta-1a on MSFC progression
in secondary progressive MS. Neurology 2002; 59(5):679-87. Level of Evidence: 1b
80. Freeman JA, Thompson AJ, Fitzpatrick R, et al. Interferon-beta1b in the treatment of
secondary progressive MS: impact on quality of life. Neurology 2001; 57(10):1870-5.
Level of Evidence: 1b
81. Freeman JA, Thompson AJ. Community services in multiple sclerosis: still a matter of
chance. J Neurol neurosurg psychiatry 2000; 69(6):728-32. Level of Evidence: 3
82. Gianino JM, York MM, Paice JA, et al. Quality of life: effect of reduced spasticity from
intrathecal baclofen. J Neurosci nurs 1998; 30(1):47-54. Level of Evidence: 3
83. Granger CV, Wende K, Brownscheidle CM. Use of the FIM instrument in a trial of
intramuscular interferon beta-1a for disease progression in relapsing-remitting multiple
sclerosis. Am J Phys med rehabil 2003; 82(6):427-36. Level of Evidence: 1b
84. Kobelt G, Jönsson L, Fredrikson S. Cost-utility of interferon beta-1b in the treatment of
patients with active relapsing-remitting or secondary progressive multiple sclerosis.
Eur J Health econom 2003; 4:50-9. Level of Evidence: 2b
85. Multiple Sclerosis Council for Clinical Practice Guidelines. Disease modifying therapies in
multiple sclerosis: evidence-based management strategies for disease modifying therapies
in multiple sclerosis. Paralyzed Veterans of America, 2001. Level of Evidence: 4
94. Solari A, Filippini G, Gasco P, et al. Physical rehabilitation has a positive effect on disability
in multiple sclerosis patients. Neurology 1999; 52(1):57-62. Level of Evidence: 1b
95. Sitzia J, Haddrell V, Rice-Oxley M. Evaluation of a nurse-led multidisciplinary neurological
rehabilitation programmeme using the Nottingham Health Profile. Clin rehabil 1998;
12(5):389-94. Level of Evidence: 2b
96. Patti F, Ciancio MR, Cacopardo M, et al. Effects of a short outpatient rehabilitation
treatment on disability of multiple sclerosis patients--a randomised controlled trial. J Neurol
2003; 250(7):861-6. Level of Evidence: 1b
97. Kidd D, Howard RS, Losseff NA, et al. The benefit of inpatient neurorehabilitation in
multiple sclerosis. Clin rehabil 1995; 9(3):198-203. Level of Evidence: 2b
98. Freeman JA, Langdon DW, Hobart JC, et al. The impact of inpatient rehabilitation on
progressive multiple sclerosis. Ann neurol 1997; 42(2):236-44. Level of Evidence: 1b
99. Di Fabio RP, Choi T, Soderberg J, et al. Health-related quality of life for patients with
progressive multiple sclerosis: influence of rehabilitation. Phys ther 1997; 77(12):1704-16.
Level of Evidence: 2a
100. Di Fabio R, Soderberg J, Choi T, et al. Extended outpatient rehabilitation: its influence on
symptom frequency, fatigue, and functional status for persons with progressive multiple
sclerosis. Arch phys med rehabil 1998; 79(2):141-6. Level of Evidence: 2a
101. Craig J, Young CA, Ennis M, et al. A randomised controlled trial comparing rehabilitation
against standard therapy in multiple sclerosis patients receiving intravenous steroid
treatment. J Neurol neurosurg psychiatry 2003; 74(9):1225-30. Level of Evidence: 1b
102. Aisen ML, Sevilla D, Fox N. Inpatient rehabilitation for multiple sclerosis. J Neurol rehabil
1996; 10(1):43-6. Level of Evidence: 2b
103. Barnes MP, Gilhus NE, Wender M. Task force on minimum standards for health care of
people with multiple sclerosis: June 1999. Eur J Neurol 2001; 8(3):215-20. Level of
Evidence: 4
104. Benito-Leon J, Morales JM, Rivera-Navarro J, et al. A review about the impact of multiple
sclerosis on health-related quality of life. Disabil rehabil 2003; 25(23):1291-303. Level of
Evidence: 4
105. Dierich M. Chapter 24: Bladder dysfunction. in: Burks J , Johnson K, eds. Multiple
sclerosis: diagnosis, medical management, and rehabilitation. New York: Demos Medical
Publishing, Inc, 2000. Level of Evidence: 4
106. Foley F. Talking about sexual dysfunction. New York: National Multiple Sclerosis Society,
2003. Level of Evidence: 4
107. Goodin DS, Frohman EM, Garmany GP Jr, et al. Disease modifying therapies in multiple
sclerosis: report of the Therapeutics and Technology Assessment Subcommittee of the
American Academy of Neurology and the MS Council for Clinical Practice Guidelines.
Neurology 2002; 58(2):169-78. Level of Evidence: 4
108. Henriksson F, Fredrikson S, Masterman T, et al. Costs, quality of life and disease severity
in multiple sclerosis: a cross-sectional study in Sweden. Eur J Neurol 2001; 8(1):27-35.
Level of Evidence: 3
109. Holland N. Talking about elimination problems. New York: National Multiple Sclerosis
Society, 2003. Level of Evidence: 4
110. Janardhan V. , Bakshi R. Quality of life in patients with multiple sclerosis: the impact of
fatigue and depression. J Neurol sci 2002; 205(1):51-8. Level of Evidence: 3
111. Jeffery D. Chapter 23: Pain and dysethesia. in: Burks J , Johnson K, eds. Multiple
sclerosis: diagnosis, medical management, and rehabilitation. New York: Demos Medical
Publishing, Inc, 2000. Level of Evidence: 4
112. Krupp L, Elkins L. Chapter 14: Fatigue. in: Burks J, Johnson K, eds. Multiple sclerosis:
diagnosis, medical management, and rehabilitation. New York: Demos Medical Publishing,
Inc., 2000. Level of Evidence: 4
113. LaRocca N. Chapter 22: Cognitive and emotional disorders. in: Burks J, Johnson K, eds.
Multiple sclerosis: diagnosis, medical management, and rehabilitation. New York: Demos
Medical Publishing, Inc., 2000. Level of Evidence: 4
114. LaRocca N. Talking about cognitive dysfunction. New York: National Multiple Sclerosis
Society, 2003. Level of Evidence: 4
115. Litta R. Changing relationships and roles within the family. MS in Focus 2004; 3:9-11.
Level of Evidence: 4
116. Logemann J. Chapter 28: Dysphagia. in: Burks J, Johnson K, eds. Multiple sclerosis:
diagnosis, medical management, and rehabilitation. New York: Demos Medical Publishing
Inc. , 2000. Level of Evidence: 4
117. Minden S. Talking about depression and other emotional changes. New York: National
Multiple Sclerosis Society, 2003. Level of Evidence: 4
118. Minden S, Frumin M, Erb J. Chapter 39: Treatment of disorders of mood and affect in
multiple sclerosis. in: Cohen J, Rudick R, eds. Multiple sclerosis therapeutics. Second
edition. London: Martin Dunitz Ltd, 2003. Level of Evidence: 4
119. Motta R. How to find strategies to manage the unpredictable. MS in focus 2003; 2:10-4.
Level of Evidence: 4
120. Murphy N, Confavreux C, Haas J, et al. Quality of life in multiple sclerosis in France,
Germany, and the United Kingdom. Cost of Multiple Sclerosis Study Group. J Neurol
Neurosurg Psychiatry 1998; 65(4):460-6. Level of Evidence: 3
121. Patti F, Ciancio MR, Reggio E, et al. The impact of outpatient rehabilitation on quality of life
in multiple sclerosis. J Neurol 2002; 249(8):1027-33. Level of Evidence: 1b
122. Rizzo M. Chapter 40: Treatment of pain, paresthesias, and paroxysmal disorders in multiple
sclerosis. in: Cohen J, Rudick R, eds. Multiple scleroris therapeutics. Second edition.
London: Martin Dunitz Ltd, 2003. Level of Evidence: 4
123. Samkoff L, Goodman A. Chapter 34: Disease modifying drug therapy for multiple sclerosis
in clinical practice. in: Cohen J, Rudick R, eds. Multiple sclerosis therapeutics. Second
edition. London: Martin Dunitz Ltd, 2003. Level of Evidence: 4
124. Multiple Sclerosis Council for Clinical Practice Guidelines. Fatigue and multiple sclerosis:
evidence-based management strategies for fatigue in multiple sclerosis. Paralyzed
Veterans of America, 1998. Level of Evidence: 4
125. Multiple Sclerosis Council for Clinical Practice Guidelines. Urinary dysfunction and multiple
sclerosis: evidence-based management strategies for urinary dysfunction in multiple
sclerosis. Paralyzed Veterans of America, 2001. Level of Evidence: 4
126. Multiple Sclerosis Society of Ireland. Diagnosed with MS? Dublin: 2003. Level of
Evidence: 4
127. Multiple Sclerosis Society of Ireland. Taking control of your emotions. Dublin: 2003. Level
of Evidence: 4
128. National Multiple Sclerosis Society. Management of MS-related fatigue. expert opinion
paper. New York: National Multiple Sclerosis Society [Web Page]. 2002; Available at
www.nationalmssociety.org. (Accessed 17 April 2003). Level of Evidence: 4
129. Brechin M, Burgess M. Designing an education tool for MS patients. Prof nurse 2001;
16(11):1471-4. Level of Evidence: 4
130. Janssens A, van Doorn P, de Boer J, et al. Impact of recently diagnosed multiple sclerosis
on quality of life, anxiety, depression and distress of patients and partners. Acta neurol
Scand 2003; 108( 6):389-95. Level of Evidence: 2b
131. Johnson J. On receiving the diagnosis of multiple sclerosis: managing the transition. Mult
scler 2003; 9(1):82-8. Level of Evidence: 2b
132. Parkin D, Jacoby A, McNamee P, et al. Treatment of multiple sclerosis with interferon beta:
an appraisal of cost-effectiveness and quality of life. J Neurol neurosurg psychiatry 2000;
68(2):144-9. Level of Evidence: 2b
133. Porter B, Keenan E. Nursing at a specialist diagnostic clinic for multiple sclerosis.
Br J Nurs 2003; 12(11):650-6. Level of Evidence: 4
134. Vermersch P, de Seze J, Delisse B, et al. Quality of life in multiple sclerosis: influence of
interferon-beta1 a (Avonex) treatment. Mult scler 2002; 8(5):377-81. Level of Evidence: 2b
135. Vanage SM, Gilbertson KK, Mathiowetz V. Effects of an energy conservation course on
fatigue impact for persons with progressive multiple sclerosis. Am J Occup ther 2003;
57(3):315-23. Level of Evidence: 2b
136. Barrett M. Sexuality and multiple sclerosis. Toronto: Multiple Sclerosis Society of Canada,
1999. Level of Evidence: 4
137. Heerings M. The role of the MS nurse. MS in focus 2003; 1 :14-6. Level of Evidence: 4
138. Rothwell PM , McDowell Z, Wong CK, et al. Doctors and patients don't agree: cross
sectional study of patients' and doctors' perceptions and assessments of disability in
multiple sclerosis. Be med J 1997; 314(7094):1580-3. Level of Evidence: 3
139. Benito-Leon J, Morales JM, Rivera-Navarro J. Health-related quality of life and its
relationship to cognitive and emotional functioning in multiple sclerosis patients.
Eur J Neurol 2002; 9(5):497-502. Level of Evidence: 3
140. Amato MP, Ponziani G, Rossi F, et al. Quality of life in multiple sclerosis: the impact of
depression, fatigue and disability. Mult scler 2001; 7(5):340-4. Level of Evidence: 3
141. National Multiple Sclerosis Society. Disease management consensus statement. New
York: National Multiple Sclerosis Society [Web Page]. 2002; Available at
www.nationalmssociety.org. (Accessed 13 March 2003). Level of Evidence: 4
142. Mathiowetz V, Matuska KM, Murphy ME. Efficacy of an energy conservation course for
persons with multiple sclerosis. Arch phys med rehabil 2001; 82(4):449-56. Level of
Evidence: 1b
143. Flensner G, Lindencrona C. The cooling-suit: case studies of its influence on fatigue
among eight individuals with multiple sclerosis. J Adv nurs 2002; 37(6):541-50. Level of
Evidence: 3
144. Foley FW, LaRocca NG, Sanders AS, et al. Rehabilitation of intimacy and sexual
dysfunction in couples with multiple sclerosis. Mult scler 2001; 7(6):417-21. Level of
Evidence: 2b
145. Fruehwald S , Loeffler-Stastka H, Eher R, et al. Depression and quality of life in multiple
sclerosis. Acta neurol Scand 2001; 104(5):257-61. Level of Evidence: 3
146. Metz LM, Patten SB, Archibald CJ, et al. The effect of immunomodulatory treatment on
multiple sclerosis fatigue. J Neurol neurosurg psychiatry 2004; 75(7):1045-7. Level of
Evidence: 3
147. Mohr D, Cox D. Multiple sclerosis: empirical literature for the clinical health psychologist.
J Clin psychol 2001; 57(4):479-99. Level of Evidence: 4
148. Ward N, Winters S. Results of a fatigue management programmeme in multiple sclerosis.
Br J Nurs 2003; 12(18):1075-80. Level of Evidence: 2b
149. Kasser SL, Stuart ME. Psychological well-being and exercise behavior in persons with and
without multiple sclerosis. Clin Kisesiol 2001; 55(4 ):81-6. Level of Evidence: 3
150. Beatus J, O'Neill JK, Towesend T, et al. The effect of a one-week retreat on self-esteem,
quality of life, and functional ability for persons with multiple sclerosis. Neurol rep 2002;
26(3):154-9. Level of Evidence: 2b
151. Consortium of Multiple Sclerosis Centers. Multiple sclerosis quality of life inventory:
technical supplement. New York: National Multiple Sclerosis Society, 1997. Level of
Evidence: 3
152. Multiple Sclerosis International Federation. MS - the disease [Web Page]. Available at
www.msif.org. (Accessed 7 June 2004). Level of Evidence: 4
153. Devitt R, Chau B, Jutai JW. The effects of wheelchair use on the quality of life of persons
with multiple sclerosis. Occup ther health care 2003; 17(3/4):63-79. Level of Evidence: 3
154. Blake DJ, Bodine C. An overview of assistive technology for persons with multiple
sclerosis. J Rehabil res dev 2002; 39(2):299-312. Level of Evidence: 4
155. Flynn S. Multiple sclerosis: the treetops model of residential care. Br J Nurs 2002;
11(9):635-42. Level of Evidence: 3
156. Buchanan RJ , Wang S, Ju H. Analyses of the minimum data set: comparisons of nursing
home residents with multiple sclerosis to other nursing home residents. Mult scler 2002;
8(6):512-22. Level of Evidence: 3
157. Buchanan R, Lewis K. Services that nursing facilities should provide to residents with MS:
a survey of health professionals. Rehabil nurs 1997; 22(2):67-72. Level of Evidence: 4
158. Sutherland G, Andersen MB, Stoove MA. Can aerobic exercise training affect
health-related quality of life for people with multiple sclerosis? J Sport exercise
psychol 2001; 23(2):122-35. Level of Evidence: 1b
159. Stuifbergen AK, Roberts GJ. Health promotion practices of women with multiple sclerosis.
Arch phys med rehabil 1997; 78(12 Suppl 5):S3-9. Level of Evidence: 2b
160. Stuifbergen AK, Seraphine A, Roberts G. An explanatory model of health promotion and
quality of life in chronic disabling conditions. Nurs res 2000; 49(3):122-9. Level of
Evidence: 3
161. Oken BS, Kishiyama S, Zajdel D, et al. Randomized controlled trial of yoga and exercise in
multiple sclerosis. Neurology 2004; 62(11):2058-64. Level of Evidence: 1b
162. Mostert S, Kesselring J. Effects of a short-term exercise training programme on aerobic
fitness, fatigue, health perception and activity level of subjects with multiple sclerosis. Mult
scler 2002; 8(2):161-8. Level of Evidence: 1b
163. Husted C, Pham L, Hekking A, et al. Improving quality of life for people with chronic
conditions: the example of t'ai chi and multiple sclerosis. Altern ther health med 1999;
5(5):70-4. Level of Evidence: 3
164. Becker H, Stuifbergen A. What makes it so hard? Barriers to health promotion
experienced by people with multiple sclerosis and polio. Fam community health 2004;
27(1):75-85. Level of Evidence: 3
165. Rogers S. Things I wish someone had told me: practical thoughts for people newly
diagnosed with multiple sclerosis. Lidcombe: MS Society of Australia. Level of Evidence: 4
166. Stuifbergen AK. Physical activity and perceived health status in persons with multiple
sclerosis. J Neurosci nurs 1997; 29(4):238-43. Level of Evidence: 3
167. Petajan JH, Gappmaier E, White AT, Spencer MK, Mino L, Hicks RW. Impact of aerobic
training on fitness and quality of life in multiple sclerosis. Ann neurol 1996; 39(4):432-41.
Level of Evidence: 1b
168. Cheng E, Myers L, Wolf S, et al. Mobility impairments and use of preventive services in
women with multiple sclerosis: observational study. BMJ 2001; 323(7319):968-9. Level
of Evidence: 3
169. Schwartz L, Kraft GH. The role of spouse responses to disability and family environment in
multiple sclerosis. Am J Phys med rehabil 1999; 78(6):525-32. Level of Evidence: 3
170. Rivera-Navarro J, Morales-Gonzalez JM, Benito-Leon J. Informal caregiving in multiple
sclerosis patients: data from the Madrid Demyelinating Disease Group study. Disabil
rehabil 2003; 25(18):1057-64. Level of Evidence: 3
171. Sato A, Ricks K, Watkins S. Needs of caregivers of clients with multiple sclerosis. J
Community health nurs 1996; 13(1):31-42. Level of Evidence: 3
172. McKeown LP, Porter-Armstrong AP, Baxter GD. Caregivers of people with multiple
sclerosis: experiences of support. Mult scler 2004; 10(2):219-30. Level of Evidence: 3
173. McKeown LP, Porter-Armstrong AP, Baxter GD. The needs and experiences of caregivers
of individuals with multiple sclerosis: a systematic review. Clin rehabil 2003; 17(3):234-48.
Level of Evidence: 4
174. Harrison T, Stuifbergen A. Disability, social support, and concern for children: depression in
mothers with multiple sclerosis. J Obstet gynecol neonatal nurs 2002; 31(4):444-53.
Level of Evidence: 3
175. Hainsworth MA. Helping spouses with chronic sorrow related to multiple sclerosis. J
Psychosoc nurs ment health serv 1996; 34(6):36-40. Level of Evidence: 3
176. Gregory RJ, Disler P, Firth S. Caregivers of people with multiple sclerosis: a survey in New
Zealand. Rehabil nurs 1996; 21(1):31-7. Level of Evidence: 3
177. Dewis ME, Niskala H. Nurturing a valuable resource: family caregivers in multiple sclerosis.
Axone 1992; 13(3):87-94. Level of Evidence: 3
178. Chipchase SY, Lincoln NB. Factors associated with carer strain in carers of people with
multiple sclerosis. Disabil rehabil 2001; 23(17):768-76. Level of Evidence: 3
179. Cheung J, Hocking P. The experience of spousal carers of people with multiple sclerosis.
Qual health res 2004; 14(2):153-66. Level of Evidence: 3
180. Boeije H, Duijnstee M, Grypdonck M. Continuation of caregiving among partners who give
total care to spouses with multiple sclerosis. Health soc care community 2003;
11(3):242-52. Level of Evidence: 3
181. Aronson KJ. Quality of life among persons with multiple sclerosis and their caregivers.
Neurology 1997; 48(1):74-80. Level of Evidence: 3
182. Aronson KJ, Cleghorn G, Goldenberg E. Assistance arrangements and use of services
among persons with multiple sclerosis and their caregivers. Disabil rehabil 1996;
18(7):354-61. Level of Evidence: 3
183. Cockerill R , Warren S. Care for caregivers: the needs of family members of MS patients.
J Rehabil 1990; 56(1):41-4. Level of Evidence: 3
184. Miller D. Caring for the carers. MS in Focus 2004; 3:12-6. Level of Evidence: 4
185. Carton H, Loos R, Pacolet J, et al. A quantitative study of unpaid caregiving in multiple
sclerosis. Mult scler 2000; 6(4):274-9. Level of Evidence: 3
186. Beatty WW, Blanco CR, Wilbanks SL, et al. Demographic, clinical, and cognitive
characteristics of multiple sclerosis patients who continue to work. J Neurol rehabil 1995;
9(3):167-73. Level of Evidence: 3
187. Busche KD, Fisk JD, Murray TJ, et al. Short term predictors of unemployment in multiple
sclerosis patients. Can J Neurol sci 2003; 30(2):137-42. Level of Evidence: 3
188. Fraser RT, Johnson EK, Clemmons DC, et al. Vocational rehabilitation in multiple sclerosis
(MS): a profile of clients seeking services. Work 2003; 21(1):69-76. Level of Evidence: 3
189. Jongbloed L . Factors influencing employment status of women with multiple sclerosis.
Can J Rehabil 1996; 9(4):213-22. Level of Evidence: 3
190. McCabe MP, De Judicibus M. Multiple sclerosis and economic well-being: role of health,
age, and duration of illness. J Clin psychol med settings 2003; 10(3):139-47.
Level of Evidence: 3
191. Thapar N., Bhardwaj S.M. Overcoming the tyranny of space: experiences of multiple
sclerosis patients. Social work abstracts 2000; 36(2):822. Level of Evidence: 3